Chinese American Biopharmaceutical Society
Howard Huang serves as the Senior Vice President and Head of Business Development and Sales at CPC Scientific Inc. since August 2012, contributing to the company’s growth as a leading peptide and oligonucleotide CDMO and CRO. In addition, Howard holds the position of Managing Director at Lake Capital and is a Leadership Team Member of the American Association of Pharmaceutical Scientists. As an Advisor and Co-Chair for the Chinese American Biopharmaceutical Society, Howard plays a pivotal role in promoting industry engagement. Previous experience includes various roles at GenScript Corporation and serving as Executive Director for the Sino-American Pharmaceutical Professionals Association. Howard holds a certificate in Strategic and Conceptual Selling from Texas A&M University and has a background in chemical technology from Beijing University of Chemical Technology.
This person is not in any teams
Chinese American Biopharmaceutical Society
1 followers
The Chinese American Biopharmaceutical Society (CABS) is a non-profit organization for professionals in the biopharmaceutical industry. CABS is a highly influential association with more than 3,000 members and subscribers in the life sciences industry. CABS is the largest and most active Chinese biopharmaceutical association in Northern America. We organize many activities to promote Sino-US collaborations in life sciences and to provide Science & Technology Parks and life sciences companies in China with an excellent platform to promote business and to recruit talent. In addition to year-round technology and business seminars, the annual BioPacific Conference organized by CABS is a highly anticipated event that attracts hundreds of biopharmaceutical professionals and business leaders.